en · de · es · fr · pt
ipamorelin-notes.peptides6155.com › Guide › Ipamorelin Background And Receptor Selectivity — Explained

Ipamorelin Background And Receptor Selectivity — Explained

By Editorial Desk · published 2025-12-28 · last reviewed 2026-01-24 · Guide

A practical reference on ghrelin receptor: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.

Reviewed 2026-01-24. Anything still debated is marked as such rather than presented as settled.

Ipamorelin Background and Receptor Selectivity

At the molecular level, ipamorelin acts as an agonist at the growth hormone secretagogue receptor type 1a, the same G protein-coupled receptor that binds ghrelin. Receptor activation couples to Gq/11 signaling, raising intracellular calcium through inositol trisphosphate and diacylglycerol, which in turn promotes exocytosis of growth hormone from pituitary somatotroph cells. Ipamorelin binds this receptor with high affinity and shows weak activity at other secretagogue-related targets in vitro. Its action requires the intact receptor and is not reversed by growth hormone-releasing hormone antagonists.

Compared with earlier growth hormone secretagogues such as GHRP-6 and hexarelin, ipamorelin has been reported to produce less stimulation of adrenocorticotropic hormone, cortisol, and prolactin in animal and early human studies. This selectivity is usually attributed to differences in receptor subtype interactions and to the tissue distribution of the receptor. Effects on appetite appear weaker than those of ghrelin itself, although the supporting evidence base is small. Whether these differences produce a distinct clinical profile remains an open question, since controlled human trials are limited.

Ipamorelin is a synthetic pentapeptide first described in the 1990s by researchers at Novo Nordisk during a program to develop selective growth hormone secretagogues. Its sequence is Aib-His-D-2-Nal-D-Phe-Lys-NH2, incorporating two non-natural residues, alpha-aminoisobutyric acid and D-2-naphthylalanine. The C-terminus is amidated, and the material is supplied as a white lyophilized powder. The molecular formula is C38H49N9O5 and the monoisotopic mass is approximately 711.85 daltons. The short chain and modified residues give it greater resistance to enzymatic degradation than many larger peptide hormones.

Background and Structural Identity

Ipamorelin is a synthetic pentapeptide classified as a growth hormone secretagogue. Its sequence, Aib-His-D-2-Nal-D-Phe-Lys-NH2, combines three non-proteinogenic residues with a C-terminal amide. The N-terminal aminoisobutyric acid unit and the two aromatic D-amino acids distinguish it from peptides assembled only from standard L-amino acids. Its formula is C38H49N9O5, corresponding to an average mass near 711.9 Da. At neutral pH the molecule carries a net positive charge, a property that shapes its behaviour in chromatographic and electrophoretic systems.

The compound was developed at Novo Nordisk during the 1990s as part of a programme seeking secretagogues with improved selectivity. It was described in the peer-reviewed literature in 1998 alongside related pentapeptides from the same series. Investigators advanced it because it raised growth hormone output in animal models while leaving other pituitary hormones comparatively unaffected. The development code NNC 26-0161 appears in earlier reports, and ipamorelin later became the common designation in published work.

Ipamorelin at a glance

PropertyValueNotes
Molecular formulaC38H49N9O5Pentapeptide with amidated C-terminus
Molecular weight711.85 g/molMonoisotopic mass
Primary receptorGHS-R1aGhrelin receptor, Gq/11 coupled
Peptide classSynthetic pentapeptideContains two non-natural residues
Reported selectivityLower cortisol and prolactin effectObserved in animal and early human work

Handling, Storage and Analytical Verification

Common solvents for laboratory work include water, buffered saline, and dimethyl sulfoxide. Once dissolved, the peptide is exposed to hydrolysis and oxidation, and alkaline conditions accelerate breakdown. Low-binding plasticware and the addition of a carrier protein reduce losses to container surfaces, which can otherwise be substantial at low concentrations. Solutions are typically kept cold and used within days. Investigators working with the compound generally prepare fresh working dilutions rather than storing dilute stocks, and they avoid repeated warming of the same vial.

Reversed-phase high-performance liquid chromatography is the standard method for purity assessment, most often on a C18 column with a water and acetonitrile gradient and trifluoroacetic acid or formic acid as an ion-pairing agent. Mass spectrometry by electrospray or matrix-assisted laser desorption confirms the expected mass and reveals truncated or modified sequences. Amino acid analysis and sequencing provide orthogonal structural evidence. Typical impurities include deletion sequences, oxidized products, and dimeric species. Detection wavelength, usually 214 or 220 nanometers, should be reported because response factors differ between peptides.

Purity is normally reported as a percentage of total peak area, a figure that does not account for water content, residual solvents, or counterions. Trifluoroacetate and acetate are the most frequent counterions in lyophilized peptides, and they shift the true peptide content away from the mass of the powder. A separate quantitative assay is therefore needed to state content accurately. Certificates of analysis often omit these details, which makes batch-to-batch comparison difficult and limits conclusions drawn when results from different suppliers are compared.

Related pages on this site

Analytical Characterization and Storage Practice

Identity and purity assessment for a research peptide of this kind typically combines reversed-phase high-performance liquid chromatography with mass spectrometry. The chromatographic run separates related impurities and yields a purity percentage, while electrospray ionization or matrix-assisted laser desorption mass spectrometry confirms the expected molecular mass. Amino acid analysis or tandem mass spectrometry sequencing can add confidence when material is intended for quantitative work. Laboratories differ in how they calculate and report purity, so figures from different sources are not always directly comparable.

Lyophilized material is generally stored cold and dry, with desiccant, and protected from light. In solution the peptide is more vulnerable: the histidine side chain can oxidize, and repeated freeze-thaw cycles promote aggregation and loss of material to container surfaces. A mildly acidic aqueous buffer is often used for short-term handling because it limits several degradation routes. Accurate prediction of long-term stability under a given set of conditions is difficult, and published stability data remain sparse.

Published discussion of this compound is uneven. Some references describe it as a tool for probing growth hormone regulation, while others focus on analytical characterization or on comparisons with related secretagogues. Statements about selectivity, half-life and potency often trace back to a small number of original reports that later authors cite secondhand. Readers evaluating a claim should therefore check whether a figure reflects a direct measurement or a repeated citation, and whether the underlying study was conducted in animals, in isolated cells or in human volunteers.

Ipamorelin Background and Mechanism

Ipamorelin is a synthetic pentapeptide that belongs to the growth hormone secretagogue family. Its sequence is Aib-His-D-2-Nal-D-Phe-Lys-NH2, incorporating two non-natural residues that resist enzymatic breakdown. Researchers at Novo Nordisk described the compound in the 1990s while searching for agents that release growth hormone with fewer side effects than earlier secretagogues. The molecule acts as an agonist at the ghrelin receptor, also called GHS-R1a, which is expressed in the pituitary and in several peripheral tissues.

Selectivity distinguishes ipamorelin from first-generation secretagogues such as GHRP-6. At doses that reliably raise growth hormone, it shows little stimulation of adrenocorticotropic hormone or cortisol release in animal models, and it does not markedly raise prolactin or appetite. Binding at GHS-R1a on pituitary somatotrophs triggers calcium influx and pulsatile growth hormone secretion. Because the compound mimics the natural ghrelin signal, the release pattern tends to follow the body's own rhythm rather than producing a sustained elevation.

Most published work on ipamorelin comes from rodent studies and small early-phase human trials. Subcutaneous and intravenous routes have been used, while oral delivery is limited by poor absorption and rapid breakdown in the gut. The reported plasma half-life is short, on the order of two hours, and varies with species and assay method. Whether chronic use produces meaningful clinical benefit remains unresolved, and long-term safety data in humans are sparse. No major regulatory agency has approved the compound as a therapeutic drug.

Handling, Storage, and Analytical Characterization

Research quantities of ipamorelin are typically distributed as a white to off-white lyophilized powder. The solid dissolves readily in water and in aqueous buffers, and stock solutions are commonly prepared in sterile water or a mildly acidic diluent. Adsorption to plastic and glass surfaces can reduce the concentration of very dilute solutions, so containers and transfer steps deserve attention when accurate concentrations matter. Reconstituted material is generally used promptly rather than held for extended periods.

Storage recommendations for the dry solid center on low temperature and low moisture, most often -20 °C in a sealed, desiccated container protected from light. Solutions are less stable than the powder and are usually kept cold and used within a short window. Freeze-thaw cycling is a recognized source of loss, and aliquoting before freezing is a standard precaution. These practices derive from general peptide handling principles rather than from a single published stability trial, so exact shelf lives should be treated as approximate.

Supporting material

Most DNA sequencing techniques produce short fragments of sequence that need to be assembled to obtain complete gene or genome sequences. The shotgun sequencing technique (used by The Institute for Genomic Research (TIGR) to sequence the first bacterial genome, Haemophilus influenzae) generates the sequences of many thousands of small DNA fragments (ranging from 35 to 900 nucleotides long, depending on the sequencing technology). The ends of these fragments overlap and, when aligned properly by a genome assembly program, can be used to reconstruct the complete genome. Shotgun sequencing yields sequence data quickly, but the task of assembling the fragments can be quite complicated for larger genomes. For a genome as large as the human genome, it may take many days of CPU time on large-memory, multiprocessor computers to assemble the fragments, and the resulting assembly usually contains numerous gaps that must be filled in later. Shotgun sequencing is the method of choice for virtually all genomes sequenced (rather than chain-termination or chemical degradation methods), and genome assembly algorithms are a critical area of bioinformatics research.

The shortage of manufacturing facilities for the Il-86 was a problem from the outset: "The rapid modernisation of the Soviet Air Force ... has left limited scope for the expansion of commercial production ... the lack of production capacity is being remedied partly by ... international cooperation." This meant involving the Polish aircraft industry in the project.

One of the most acutely toxic indoor air contaminants is carbon monoxide (CO), a colorless and odorless gas that is a by-product of incomplete combustion. Carbon monoxide may be emitted from tobacco smoke and generated from malfunctioning fuel burning stoves (wood, kerosene, natural gas, propane) and fuel burning heating systems (wood, oil, natural gas) and from blocked flues connected to these appliances. In developed countries the main sources of indoor CO emission come from cooking and heating devices that burn fossil fuels and are faulty, incorrectly installed or poorly maintained. Appliance malfunction may be due to faulty installation or lack of maintenance and proper use. In low- and middle-income countries the most common sources of CO in homes are burning biomass fuels and cigarette smoke. Health effects of CO poisoning may be acute or chronic and can occur unintentionally or intentionally (self-harm). By depriving the brain of oxygen, acute exposure to carbon monoxide may have effects on the neurological system (headache, nausea, dizziness, alteration in consciousness and subjective weakness), the cardiovascular and respiratory systems (myocardial infarction, shortness of breath, or rapid breathing, respiratory failure). Acute exposure can also lead to long-term neurological effects such as cognitive and behavioral changes. Severe CO poisoning may lead to unconsciousness, coma and death. Chronic exposure to low concentrations of carbon monoxide may lead to lethargy, headaches, nausea, flu-like symptoms and neuropsychological and cardiovascular issues.

Sources: en.wikipedia.org

Notes from published material

In 1930, the Grand Coalition fell apart. Heinrich Brüning, from the moderate-conservative wing of the party, was appointed as Chancellor with a cabinet that, apart from the missing Social Democrats, was virtually unchanged. Brüning was confronted with economic crises exacerbated by the Great Depression and had to tackle the difficult tasks of consolidating both budget and currency when faced with rising unemployment, and of also negotiating changes to the war reparations payments. His course of strict budget discipline, with severe cuts in public expenditure, and tax increases made him extremely unpopular among the lower and middle classes as well as among the Prussian Junkers. In 1930, Brüning's failure to gain a majority for his policies in parliament prompted him to call early elections, in which the four parties of the former Grand coalition lost their majority. After this, Brüning based his administration entirely on the support of the presidential decrees ("Notverordnung") through article 48 of the Constitution. This allowed him to circumvent parliament, as long as the Social Democrats - who feared another election - tolerated this practice. For this way of government based on both the President and cooperation of parliament, Brüning coined the term "authoritarian democracy". By this time, the party had become increasingly ambivalent toward democracy. Many elements of the party, including Kaas, had come to believe that only an authoritarian regime could protect the position of the Church.

Hydrothermal vent ecosystems have enormous biomass and productivity, but this rests on the symbiotic relationships that have evolved at vents. Deep-sea hydrothermal vent ecosystems differ from their shallow-water and terrestrial hydrothermal counterparts due to the symbiosis that occurs between macroinvertebrate hosts and chemoautotrophic microbial symbionts in the former. Since sunlight does not reach deep-sea hydrothermal vents, organisms in deep-sea hydrothermal vents cannot obtain energy from the sun to perform photosynthesis. Instead, the microbial life found at hydrothermal vents is chemosynthetic; they fix carbon by using energy from chemicals such as sulfide, as opposed to light energy from the sun. In other words, the symbiont converts inorganic molecules (H2S, CO2, O) to organic molecules that the host then uses as nutrition. However, sulfide is an extremely toxic substance to most life on Earth. For this reason, scientists were astounded when they first found hydrothermal vents teeming with life in 1977. What was discovered was the ubiquitous symbiosis of chemoautotrophs living in (endosymbiosis) the vent animals' gills; the reason why multicellular life is capable to survive the toxicity of vent systems. Scientists are therefore now studying how the microbial symbionts aid in sulfide detoxification (therefore allowing the host to survive the otherwise toxic conditions). Work on microbiome function shows that host-associated microbiomes are also important in host development, nutrition, defense against predators, and detoxification.

=== Amateur === The North Carolina Tigers compete as an Australian rules football club in the United States Australian Football League, in the Eastern Australian Football League. The Raleigh Cú Chulainn Gaelic Athletic Association competes in men's and women's Gaelic Football, Hurling, and Camogie. It is a member in the Southeast Division of the United States Gaelic Athletic Association and the Gaelic Athletic Association based in Ireland. The Raleigh GAA won the Junior B Men's Football national championship in 2014. The Raleigh GAA and the North Carolina Tigers Australian rules football clubs compete in the annual Oak City Cup where both clubs compete under the compromise football rules adapted by Ireland and Australia for international competition. Raleigh is also home to one of the Cheer Extreme All Stars gyms. In 2009 and again in 2010, Cheer Extreme Raleigh's Small Senior Level 5 Team were silver medalists at the Cheerleading Worlds Competition in Orlando, Florida, and in 2012 they received the bronze medal. Raleigh is also home to one of the Southeast's premier Hardcourt Bike Polo clubs. Because of the area's many billiards rooms, Raleigh is home to one of the largest amateur league franchises for playing pool, the Raleigh, Durham, Chapel Hill American Poolplayers Association. There are leagues available in formats for players of any skill level.

==== MeSH D06.472.420 – hypothalamic hormones ==== MeSH D06.472.420.349 – pituitary adenylate cyclase-activating polypeptide MeSH D06.472.420.700 – pituitary hormone release inhibiting hormones MeSH D06.472.420.700.500 – msh release-inhibiting hormone MeSH D06.472.420.700.750 – prolactin release-inhibiting hormone MeSH D06.472.420.700.875 – somatostatin MeSH D06.472.420.740 – pituitary hormone-releasing hormones MeSH D06.472.420.740.140 – corticotropin-releasing hormone MeSH D06.472.420.740.320 – gonadorelin MeSH D06.472.420.740.320.100 – buserelin MeSH D06.472.420.740.320.340 – goserelin MeSH D06.472.420.740.320.400 – leuprolide MeSH D06.472.420.740.320.580 – nafarelin MeSH D06.472.420.740.320.790 – triptorelin MeSH D06.472.420.740.530 – msh-releasing hormone MeSH D06.472.420.740.720 – prolactin-releasing hormone MeSH D06.472.420.740.860 – somatotropin-releasing hormone MeSH D06.472.420.740.860.780 – sermorelin MeSH D06.472.420.740.880 – thyrotropin-releasing hormone

Sources: en.wikipedia.org

Frequently asked questions

What class of compound is ipamorelin?

It is a synthetic pentapeptide belonging to the growth hormone secretagogue family. Its principal characterized target is the ghrelin receptor, also called GHS-R1a. The molecule contains non-natural amino acids and an amidated C-terminus.

How does ipamorelin differ from ghrelin?

Both act at the same G protein-coupled receptor, but ipamorelin is a short synthetic peptide with modified residues rather than the natural 28-amino-acid hormone. Reports describe weaker effects on appetite and on cortisol or prolactin release than those seen with ghrelin. Its resistance to enzymatic breakdown also differs from that of the natural ligand.

Is the mechanism of action fully established?

Receptor binding and downstream calcium signaling are well characterized in cell-based systems. Effects measured in whole organisms are less consistent across studies and species. The extent to which selective receptor behavior drives the observed hormonal profile is still debated.

What type of molecule is ipamorelin?

It is a synthetic five-amino-acid peptide that acts as a growth hormone secretagogue. Three of its residues are non-standard amino acids, and the chain ends in an amide rather than a free acid. The molecule is small enough that it can be characterised by routine peptide analytical techniques.

Network